Trial Profile
A phase I study investigating the effect of combination of in-vitro educated CD8+T cells and ipilimumab in patients with metastatic melanoma
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 Dec 2015
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 30 Dec 2015 New trial record